this is an article about options trading with Amgen, which is a big medicine company. People are buying and selling things called options, which can make them a lot of money or can lose a lot of money too. Some people are buying Amgen options hoping the price will go up, and some people are selling them hoping the price will go down. The article talks about how many people are doing this and how much money is involved. Read from source...

all noticeable, particularly towards the end of the article. It's indicative of a lack of professional objectivity. The language used is often accusatory and inflammatory. There is a clear attempt to manipulate readers' emotions. The lack of balance and the obvious favoritism shown towards certain viewpoints is concerning. The article would have benefited from a more neutral, balanced, and detached approach.

BULLISH

The options trading trends discussed in the article indicate bullish tendencies, with 22% of traders showing bullish tendencies and 38% showing bearish tendencies. The unusual trades spotted in Amgen reveal an expectation of a price window of $210.0 to $370.0 for Amgen. The sentiment is bullish as the big players seem to be eyeing a price increase, which aligns with the trading tendencies observed.

Unpacking the Latest Options Trading Trends in Amgen
- It's important to know that big players have been eyeing a price window from $210.0 to $370.0 for Amgen during the past quarter, which helps in understanding the expected price movements.

- When looking at the volume and open interest, it's a powerful move while trading options. This data can help track liquidity and interest for Amgen's options for a given strike price.

- In the last month, 2 experts released ratings on this stock with an average target price of $321.5. One analyst from Morgan Stanley persists with their Equal-Weight rating on Amgen, maintaining a target price of $303, and another analyst from Argus Research continues to hold a Buy rating for Amgen, targeting a price of $340.

- The stock's current RSI values indicate that it may be overbought.

- Amgen's next earnings report is scheduled for 16 days from now.

In terms of risks, trading options can be riskier compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.